[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$phrrf](/topic/$phrrf) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "PharmaTher Applauds FDA's Commissioner's National Priority Voucher (CNPV) Selection of Ketamine; Company Highlights Potential Ketamine Opportunity 505(b)(2) Focus and Upside from Strategic ANDA Sale $PHRM $PHRRF" [X Link](https://x.com/junglejava1/status/1979168644316700846) [@junglejava1](/creator/x/junglejava1) 2025-10-17T12:52Z 25.4K followers, XXX engagements "PharmaTher Applauds FDAs Commissioners National Priority Voucher (CNPV) Selection of Ketamine; Company Highlights Potential Ketamine Opportunity 505(b)(2) Focus and Upside from Strategic ANDA Sale Press Release: $PHRRF $PHRM" [X Link](https://x.com/Pharmather_Inc/status/1979163711718764832) [@Pharmather_Inc](/creator/x/Pharmather_Inc) 2025-10-17T12:32Z 1113 followers, XXX engagements "$PHRRF News PharmaTher Advances Phase X FDA Package for Ketamine in LID-Parkinson's Disease #biotech #stocktowatch" [X Link](https://x.com/stckonwtchx/status/1978865900842295522) [@stckonwtchx](/creator/x/stckonwtchx) 2025-10-16T16:49Z XXX followers, XXX engagements "$PHRRF $PHRM News Out @Pharmather_Inc Advances Phase X FDA Package for Ketamine in LID-Parkinsons Disease" [X Link](https://x.com/stckonwtchx/status/1978802722444083631) [@stckonwtchx](/creator/x/stckonwtchx) 2025-10-16T12:38Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"PharmaTher Applauds FDA's Commissioner's National Priority Voucher (CNPV) Selection of Ketamine; Company Highlights Potential Ketamine Opportunity 505(b)(2) Focus and Upside from Strategic ANDA Sale $PHRM $PHRRF"
X Link @junglejava1 2025-10-17T12:52Z 25.4K followers, XXX engagements
"PharmaTher Applauds FDAs Commissioners National Priority Voucher (CNPV) Selection of Ketamine; Company Highlights Potential Ketamine Opportunity 505(b)(2) Focus and Upside from Strategic ANDA Sale Press Release: $PHRRF $PHRM"
X Link @Pharmather_Inc 2025-10-17T12:32Z 1113 followers, XXX engagements
"$PHRRF News PharmaTher Advances Phase X FDA Package for Ketamine in LID-Parkinson's Disease #biotech #stocktowatch"
X Link @stckonwtchx 2025-10-16T16:49Z XXX followers, XXX engagements
"$PHRRF $PHRM News Out @Pharmather_Inc Advances Phase X FDA Package for Ketamine in LID-Parkinsons Disease"
X Link @stckonwtchx 2025-10-16T12:38Z XXX followers, XXX engagements
/topic/$phrrf/posts